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Abstract
Background:  Coronary artery calcification (CAC) measured by electron-beam computed
tomography (EBCT) has been well studied in the prediction of coronary artery disease (CAD). We
sought to evaluate the impact of the CAC score in the diagnostic process immediately after its
introduction in a large tertiary referral centre.
Methods: 598 patients with no history of CAD who underwent EBCT for evaluation of CAD were
retrospectively included into the study. Ischemia detection test results (exercise stress test, single
photon emission computed tomography or ST segment analysis on 24 hours ECG detection), as
well as the results of coronary angiography (CAG) were collected.
Results: The mean age of the patients was 55 ± 11 years (57% male). Patients were divided
according to CAC scores; group A < 10, B 10 – 99, C 100 – 399 and D ≥ 400 (304, 135, 89 and 70
patients respectively). Ischemia detection tests were performed in 531 (89%) patients; negative
ischemia results were found in 362 patients (183 in group A, 87 in B, 58 in C, 34 in D). Eighty-eight
percent of the patients in group D underwent CAG despite negative ischemia test results, against
6% in group A, 16% in group B and 29% in group C. A positive ischemia test was found in 74 patients
(25 in group A, 17 in B, 16 in C, 16 in D). In group D 88% (N = 14) of the patients with a positive
ischemia test were referred for CAG, whereas 38 – 47% in group A-C.
Conclusion: Our study showed that patients with a high CAC score are more often referred for
CAG. The CAC scores can be used as an aid in daily cardiology practice to determine further
decision making.
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Background
Since coronary artery disease (CAD) is a major cause of
mortality in industrialized western countries, its detection
before complications arise has substantial clinical rele-
vance.[1,2] CAD is caused by atherosclerosis and its first
manifestations can be found as early as in the second dec-
ade of life.[3] Atherosclerotic lesions may progress to such
an extent that coronary flow is impaired. The ensuing
myocardial ischemia is clinically manifested as chest
pain.[4] Chest pain is one of the first symptoms of CAD
and also a common complain for which patients seek
medical care. Most often an exercise stress test (EST) is the
investigation of first choice in the evaluation of chest pain
patients. A positive stress test outcome pleads for underly-
ing CAD, whereas a negative test does not necessary rule
out obstructive CAD.[5] EST and other non-invasive tech-
niques, such as myocardial perfusion single photon emis-
sion computed tomography (SPECT), can only identify
patients with advanced CAD.[6,7] Thus, there is a need for
a better diagnostic procedure to detect CAD in an earlier
stage.
Electron-beam computed tomography (EBCT) can detect
and quantify coronary artery calcification (CAC). Several
studies found a strong independent association between
CAC score and CAD detected with coronary angiography
(CAG). [8-10] The sensitivity and specificity of CAC score
for detection of CAD in symptomatic patients appeared to
be 93% and 88%, respectively.[9] The negative predictive
value of EBCT varies from 95% to 100%. [10,11]
Next to being of diagnostic value, CAC score is also an
important prognostic determinant for coronary events.
The measurement of CAC is an appropriate initial screen-
ing tool in patients at increased coronary risk.[12] Symp-
tomatic patients with excessive CAC score carry a high risk
for future events.[13] A negative CAC score has been asso-
ciated with a very low event rate of 0.4 events per 1000 per
year.[14] The negative predictive value of CAC score is of
great value for cardiologists as well as general practition-
ers, which means that CAC score is an important identifier
of low risk patients.
As yet, there is little information about the implementa-
tion of EBCT for clinical decision making in routine clini-
cal practice. The question whether negative or positive
EBCT outcome influences the decision of the clinician for
further diagnostic investigations has still to be answered.
The aim of this study is to evaluate the contribution of
EBCT derived CAC score in the management of patients
suspected of CAD by clinicians.
Methods
Between November 2004 and March 2006, 1008 patients
were referred to the University Medical Centre Groningen
(a tertiary referral centre) for cardiac EBCT. Thirty-six sub-
jects with a history of CAD were excluded (history of myo-
cardial infarction, percutaneous coronary intervention or
coronary artery bypass graft). In addition patients referred
for evaluation of aortic valve stenosis (n = 67), or atrial
dimensions (n = 55) were excluded, as well as those being
referred for pre-operative screening (n = 70) or research
purposes (n = 182). The study population of our retro-
spective observational study consisted of 598 patients
referred for the evaluation of CAD. They underwent addi-
tional diagnostic procedures for evaluation of myocardial
ischemia, as being clinically relevant according to the
treating cardiologist; e.g. EST, ST segment analysis on 24
hours ECG registration, and myocardial perfusion SPECT.
If judged clinically relevant, a CAG was performed. The
Framingham Risk Score was calculated for each patient to
determine the 10-year cardiovascular risk.[15] Figure 1
shows images of performed diagnostic procedures from
one of the included patients. Due to the nature of this
study (retrospective observational study), the institutional
review board concluded that the study was exempt from
the obtainment of ethical approval.
Myocardial ischemia tests
Exercise stress test
Patients underwent EST in accordance with the guidelines
of the American Heart Association.[16] ECG was recorded
at rest and during exercise. Exercise began at 25 watt, fol-
lowed by an increase of 10 to 25 watt every 2 minutes
depending on patient's age, gender, and weight. ST seg-
ments were monitored continuously. The exercise was ter-
minated upon maximum exertion (e.g. exhaustion,
dyspnoea), in the absence of ECG changes suggestive for
ischemia or other mandatory end-points (e.g. drop in
systolic blood pressure (≥ 10 mm Hg), anginal com-
plaints, ischemic ST segment changes, serious arrhyth-
mias, urgent request to stop). In case of a maximum heart
rate < 85% of the predicted maximum or non-diagnostic
ECG changes, the test was considered to be non-conclu-
sive.
ST segment analysis on twenty four hour ECG registration
Twenty-four hour ECG registration was performed using 4
channel Holter recorders (GE Marquette series 8500, Mil-
waukee, WI). Modified leads aVF, V1 and V5 were used.
The ECG was analysed on GE Marquette MARS analyser
and reviewed by an experienced analyst and supervised by
a cardiologist. The rule of 1-1-1 was applied as a criterium
for ST-segment analysis.[17]
Myocardial perfusion single photon emission computed tomography
A standardized protocol was used for myocardial per-
fusion SPECT. A rest SPECT was performed, after injection
of 600 MBq of 99 mTc-tetrofosmin, including gated images
in 8 frames at an R-R interval of ± 10%. The next day stressBMC Cardiovascular Disorders 2008, 8:38 http://www.biomedcentral.com/1471-2261/8/38
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Images of a 66-year-old symptomatic man who had a coronary artery calcification score of 671; A: electron-beam computed  tomography, B: myocardial perfusion single photon emission computed tomography (SPECT), C: coronary angiography (CAG) Figure 1
Images of a 66-year-old symptomatic man who had a coronary artery calcification score of 671; A: electron-
beam computed tomography, B: myocardial perfusion single photon emission computed tomography 
(SPECT), C: coronary angiography (CAG). Circles define regions of coronary calcification. SPECT demonstrated myo-
cardial perfusion defect in the apex and anteroseptal region after bicycle stress test (upper rows). These were completely 
reversible during myocardial perfusion rest test. CAG revealed 1-vessel disease of the left anterior descending artery, with col-
lateral filling from the right coronary artery. Arrow indicates the occlusion of the left anterior descending artery. Based on 
these results, the patient was accepted for coronary artery bypass graft surgery.BMC Cardiovascular Disorders 2008, 8:38 http://www.biomedcentral.com/1471-2261/8/38
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SPECT was performed after adenosine or bicycle exercise.
SPECT images were acquired one hour after tracer admin-
istration using a double headed gamma-camera (Ecam,
Siemens Medical Systems, Chicago, IL) equipped with
low-energy high-resolution collimators. The camera
heads were in perpendicular position. Other acquisition
parameters were: 32 steps rotation, 20 sec per step, 128 ×
128 matrix size, rotation from the 45° right anterior
oblique to the 135° left posterior oblique position with
the patient laying supine. SPECT images were recon-
structed after filtered-back-projection using a Butterworth
0.30/6 filter. All data were re-orientated in order to pro-
duce short-axis, horizontal long-axis and vertical long-axis
sections. The myocardial perfusion SPECT images were
analysed by a panel of nuclear medicine physicians and
cardiologists.
The quantitative gated SPECT analysis program was used
for assessing myocardial perfusion.[18] Segmental myo-
cardial perfusion was analyzed quantitatively and seg-
mental tracer activity was categorized on a 4-point scale of
1 = normal tracer activity > 75%, 2 = 50% to 75% tracer
activity, 3 = 25% to 50% tracer activity, and 4 = tracer
activity < 25%. Perfusion defects on stress images were
considered present when tracer activity was < 75% of max-
imum. When significant fill-in (>10%) of perfusion
defects was observed on the images at rest, segments were
classified as ischemic, whereas defects without fill-in (≤
10%) were considered scar tissue.
The results of EST, ST segment analysis on 24 hours ECG
registration or myocardial perfusion SPECT were com-
bined and divided into 3 groups: (1) negative, (2) non-
conclusive or (3) positive for myocardial ischemia. A non-
conclusive test overruled another negative test, except for
a negative SPECT. A positive test overruled a negative or
non-conclusive test in any case.
Electron-beam computed tomography
All patients underwent EBCT scan (C-150 Imatron, Gen-
eral Electrics, San Francisco, CA). Beginning from the aor-
tic root, 38 images were obtained with 100 ms scan time
and 3 mm slice thickness. During a single breath-hold, the
images were acquired at 80% of the R-R interval, using
ECG-triggering. Scans were made with 130 kV and 895
mAs. The entire procedure lasted 15 minutes per patient,
including the time for assessing CAC score. A CAC score
was determined according to the methods described by
Agatston et al, using a commercially available calcium
scoring software package (SmartScore, GE Healthcare, San
Francisco, CA).[19] CAC scores were divided into < 10,
10–99, 100–399 and ≥ 400. In case of a CAC score of ≥
400 a CAG was advised.
Coronary angiography
CAG was performed according to standard procedure. At
least two orthogonal views of the right coronary artery and
at least five views of the left coronary system were made.
A significant stenosis was defined as a luminal narrowing
of ≥ 50%. In case of such significant stenosis, the patients
were considered to have significant CAD. In case no CAG
was performed, presence of CAD was determined to be
unknown.
Statistical analysis
We analysed data with SPSS version 12.01. Data are
reported as mean ± SD for parametric variables, as median
and interquartile range for non-parametric variables, and in
the case of nominal variables as percent frequency. In case
of nominal variable, we used the chi-square test for analysis
of differences between 2 groups. To compare not normally
distributed data between 2 groups, the Mann-Whitney U
test was used and a Students t-test in case of normally dis-
tributed data. To analyze differences between > 2 groups,
we used the Kruskall-Wallis test in case of skewed or dichot-
omous data, and ANOVA in case of normally distributed
data. A p-value < 0.05 was considered to be significant. The
Framingham Risk Score was used to calculate the 10-year
risk of coronary heart disease.[15] Multivariable Cox regres-
sion was used to evaluate the association between clinical
variables and the probability of undergoing CAG. CAC
score group, ischemia test result and traditional cardiovas-
cular risk factors (age, sex, diabetes mellitus, hypertension,
hypercholesterolemia, smoking habit and family history of
cardiovascular disease) were added to the model. In
another model CAC score groups were changed for contin-
uous CAC score. Data are expressed as hazard ratios (HR)
with 95% confidence intervals (CI). A p value < 0.05 was
considered statistically.
Results
In total, 598 patients met the inclusion criteria (age 55 ± 11
years, 57% male). Clinical characteristics of the patients are
shown in table 1. Patients were divided into four groups
based on their CAC score: group A CAC score < 10; group B
CAC score 10–99; 100–399; group D CAC scores ≥ 400
(304, 135, 89 and 70 patients respectively). In 531 (89%)
patients additional diagnostic tests were performed to
screen for myocardial ischemia; 446 EST, 135 ST segment
analyses on 24 hours ECG registration, and 135 myocardial
perfusion SPECT. One-hundred-forty-six patients (24%)
underwent CAG. Figure 2 shows the results of ischemia
tests divided per CAC score group (A-D).
No cardiovascular risk factors were present in 72 (12%)
patients. At least one cardiovascular risk factor was present
in 526 (88%) patients: 150 (25%) had one and 376
(63%) had two or more risk factors. Typical chest pain wasBMC Cardiovascular Disorders 2008, 8:38 http://www.biomedcentral.com/1471-2261/8/38
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recorded in 127 (21%) patients, atypical chest pain in 388
(65%) and 83 (14%) patients had no chest pain. This last
group was referred for cardiac EBCT based on high cardi-
ovascular risk profile, and/or abnormal ECG.
Coronary artery calcification and coronary angiography
The probability to undergo CAG increases if a patient
belongs to a higher CAC score group (p < 0.001, table 2);
9% of group A underwent CAG, 22% of group B, 34% of
group C and 86% of group D. If we consider the patients
with a negative ischemia test result, the probability of
undergoing a CAG also increases with CAC score (p <
0.001, figure 3); 1% of group A underwent CAG, 16% of
group B, 29% of group C and 88% of group D. The same
applies to the patients with a positive ischemia test (p <
0.05); 44% of group A underwent CAG, 47% of group B,
38% of group C and 88% of group D.
598 patients, divided into 4 groups (A – D) underwent electron-beam computed tomography Figure 2
598 patients, divided into 4 groups (A – D) underwent electron-beam computed tomography. In 531 an ischemia 
test was performed, being either non-conclusive, negative or positive. One-hundred-forty-six patients underwent CAG and in 
59 significant CAD was found. CAC = coronary artery calcification; CAD = coronary artery disease; CAG = coronary angiog-
raphy; O = no ischemia test; +/- = non-conclusive result; - = negative ischemia test; + = positive ischemia test.BMC Cardiovascular Disorders 2008, 8:38 http://www.biomedcentral.com/1471-2261/8/38
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Twenty-five patients in group A had a positive ischemia
test. Eleven of these patients were referred for CAG, their
CAC score was not significantly different from those not
referred for CAG; 1 (0 – 3) versus 0 (0 – 3). In group A 183
patients had a negative ischemia test; 11 of which under-
went CAG. The CAC score did not differ between those
referred or not; 0 (0 – 2) and 0 (0 – 1) respectively. More-
over, this applies also to group B, C and D.
If we consider all patients with a CAC score ≥ 10, 49
patients had a positive ischemia test. Twenty-eight of
them were referred for CAG, they had a significant higher
CAC score as the 21 that were not referred; 428 (83 – 892)
versus 121 (69 – 222) (p < 0.05). Interestingly, the 61
patients with a CAC score ≥ 10, who were referred for CAG
despite a negative ischemia test had a CAC of 389 (119 –
639) versus 66 (40 – 173) in the 118 patients that were
not referred for CAG (p < 0.001). The same applies to the
whole population; the 72 patients who were referred for
CAG despite a negative ischemia test had a CAC score of
315 (58 – 595) against 1 (0 – 51) in the 290 patients that
were not referred for CAG (p < 0.001). If the ischemia test
was non-conclusive patients referred for CAG had higher
CAC scores than those not; 258 (32 – 831) and 0 (0 – 11)
respectively (p < 0.001).
In 67 out of 598 patients, no ischemia detection tests were
performed. Ten of them underwent CAG (CAC score 641
(70 – 1198)) and significant CAD was found in 5 of them
(CAC score 1016 (407 – 2633)).
Multivariable Cox regression
Regression analysis showed a significant association
between CAC score group (A-D) and CAG referral (p <
0.001), see table 3. If ischemia test results were added to
the model, the association did not change. Ischemia test
results were also significantly associated to CAG referral (p
< 0.001). Also, if traditional cardiovascular risk factors
were taken into account, the association between CAC
score groups and CAG referral did not change. Because a
CAG was advised in case of a CAC score of ≥ 400, we per-
formed regression analyses for the population with a CAC
score < 400. The association between CAC score group (A-
C) and CAG referral remained significant after correction
for ischemia test results and traditional cardiovascular risk
factors (p < 0.05), see table 3.
Regression analysis showed a significant association
between continuous CAC score and the probability of
undergoing CAG (HR 1.01; 95% CI 1.00 – 1.01, p <
0.001). Adjustment for ischemia test result and traditional
risk factors did not change the association between CAC
score and probability of undergoing CAG (HR 1.01; 95%
CI 1.00 – 1.01, p < 0.001). These results did not change if
we only included patients with a CAC score < 400 into the
regression analysis.
Table 1: Baseline patient characteristics of whole study population and divided into group A (CAC score < 10), group B (CAC score 
10–99), group C (CAC score 100–399), group D (CAC score ≥ 400)
All AB C D
N 598 304 135 89 70
Male* 338 (57%) 156 (51%) 80 (59%) 60 (67%) 42 (60%)
Age (years)* 55 ± 11 50 ± 11 56 ± 10 62 ± 10 63 ± 10
CAC score* 13 (0–158) 0 (0–1) 44 (24–65) 224 (148–295) 693 (511–1284)
Risk factors
Hypertension* 231 (57%) 138 (45%) 74 (55%) 60 (67%) 55 (79%)
Diabetes 47 (12%) 24 (8%) 20 (15%) 11 (12%) 8 (11%)
Hypercholesterolemia* 164 (41%) 100 (33%) 61 (45%) 40 (45%) 41 (59%)
Smoking 117 (29%) 109 (36%) 51 (38%) 39 (44%) 25 (36%)
Family history of CVD 209 (52%) 159 (52%) 67 (50%) 39 (44%) 42 (60%)
10-year risk of CHD (%)* 6 (3–10) 4 (2–8) 6 (4–10) 10 (6–12) 8 (5–12)
CVD history
Atrial fibrillation 25 (7%) 12 (4%) 2 (2%) 5 (6%) 6 (9%)
Cerebrovascular disease 16 (4%) 13 (4%) 9 (7%) 6 (7%) 2 (3%)
Other 36 (10%) 17 (6%) 12 (9%) 10 (11%) 9 (13%)
Ischemia test 531 (89%) 263 (87%) 122 (90%) 85 (96%) 61 (87%)
Negative 362 (61%) 183 (60%) 87 (64%) 58 (65%) 34 (49%)
Non-conclusive 95 (16%) 55 (18%) 18 (13%) 11 (12%) 11 (16%)
Positive* 74 (12%) 25 (8%) 17 (13%) 16 (18%) 16 (23%)
CAG* 146 (24%) 26 (9%) 30 (22%) 30 (34%) 60 (86%)
Values are mean ± SD or median (interquartile range). CAC = coronary artery calcification, CAG = coronary angiography, CHD = coronary heart 
disease, CVD = cardiovascular disease. * Significant difference between groups, p < 0.05. Framingham Risk Score was used to determine 10-year 
risk of CHD. Other: cardiovascular history includes valvular diseases, arrhythmias, peripheral arterial disease, dilated cardiomyopathy, heart failure, 
myocarditis, pericarditis, and pulmonary embolism.BMC Cardiovascular Disorders 2008, 8:38 http://www.biomedcentral.com/1471-2261/8/38
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Discussion
We found an important impact of CAC measurements on
clinical decision making, whether to perform additional
invasive CAG or not. Especially in patients with a negative
ischemia test result CAG referral was more likely chosen in
case of a higher CAC score. Ischemia test results do not
influence the clinical decision making in case a patient has
a CAC score ≥ 400.
The value of CAC for the prediction of CAD and cardio-
vascular events has been well-established. CAC identifies
anatomical correlates of CAD. Moreover, it has been
shown that the CAC score is an important predictor of
ischemia on SPECT.[20] However, there is no significant
difference in the overall diagnostic performance between
EBCT and SPECT.[9]
There are several benefits of EBCT over cardiac stress tests.
First, coronary blood flow does not have to be compro-
mised for the detection. Second, the accuracy of EST is
limited by the ability of the patient to exercise or to base-
line ECG abnormalities, whereas EBCT does not have
these limitations. Third, other important possible sources
of the chest pain, such as pneumonia, pericarditis, and
aortic disease, can be seen on the EBCT.
The focus of our study was to obtain information about
the impact of EBCT on the clinical decision for further
diagnostic investigations. We found that the CAC score is
an important determinant for the decision whether to per-
form CAG, as is shown in figure 2, especially in case of a
negative stress test. In addition, in the total population the
CAC score was higher in patients undergoing CAG, inde-
pendent of ischemia test results. Furthermore, 26 patients
Percentage of patients of group A (CAC score < 10), group B (CAC score 10–99), group C (CAC score 100–399), group D  (CAC score ≥ 400) undergoing coronary angiography in case the ischemia test result was negative or positive Figure 3
Percentage of patients of group A (CAC score < 10), group B (CAC score 10–99), group C (CAC score 100–
399), group D (CAC score ≥ 400) undergoing coronary angiography in case the ischemia test result was nega-
tive or positive. CAC = coronary artery calcification.BMC Cardiovascular Disorders 2008, 8:38 http://www.biomedcentral.com/1471-2261/8/38
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underwent CAG from group A, despite a negative EBCT
result, and significant CAD was found in only 1 of them.
None of the 183 patients in group A with a negative
ischemia test (11 CAG were performed, 6%), appeared to
have significant CAD, in contrast to 21 of 179 patients
with a CAC score ≥ 10 (61 CAG were performed, 34%). In
addition, none of the patients in group A with a positive
ischemia test result appeared to have significant CAD.
Due to its high sensitivity, EBCT might help to identify
false positive ischemia test results.[10,11] However, the
specificity remains low; in our study 35 of 135 (26%)
patients with a CAC score ≥ 400 showed significant CAD
on CAG. Moreover, previous reports have shown that 31–
47% patients with a CAC score ≥ 400 had a normal SPECT
result.[20,21] As a marker of CAD, the CAC score can pre-
dict long-term coronary risk. However, the rather low spe-
cificity does not make it a good predictor of obstructive
CAD. Sending patients with abnormal EBCT results to
CAG without having positive ischemia test results is not
beneficial, as the patient will be exposed to the risk of an
invasive procedure without the need for revasculariza-
Table 2: CAC score and results of ischemia tests in group A (CAC score < 10), group B (CAC score 10–99), group C (CAC score 100–
399) and group D (CAC score ≥ 400) according to CAG referral
CAG referral
Yes No
N CAC score N CAC score
Total population* 146 269 (37 – 629) 452 1 (0 – 48)
Group A† 26 0 (0 – 2) 278 0 (0 – 1)
Group B 30 47 (28 – 73) 105 44 (23 – 64)
Group C† 30 256 (161 – 354) 59 203 (140 – 268)
Group D† 60 771 (538 – 1398) 10 568 (456 – 729)
No ischemia test* 10 642 (70 – 1198) 57 0 (0 – 20)
Ischemia test* 136 256 (31 – 613) 395 1 (0 – 53)
Negative* 72 315 (58 – 595) 290 1 (0 – 51)
Non-conclusive* 25 258 (32 – 831) 70 0 (0 – 11)
Positive† 39 130 (7 – 620) 35 57 (0 – 192)
Values are median (interquartile range). CAC = coronary artery calcification, CAG = coronary angiography. Significant difference in CAC score; * p 
< 0.001, † p < 0.05
Table 3: Hazard ratios: Cox regression
All CAC score groups included CAC score group A-C included
Univariable HR (95% CI) P-value HR (95% CI) P-value
CAC score group A reference reference
B 3.06 (1.73–5.41) <0.001 3.06 (1.73–5.41) <0.001
C 5.44 (3.00–9.86) <0.001 5.44 (3.00–9.86) <0.001
D 64.2 (29.4–140) <0.001 -
Multivariable HR (95% CI) P-value HR (95% CI) P-value
CAC score group A reference reference
B 3.28 (1.19–4.37) <0.001 2.38 (1.23–4.60) 0.01
C 3.88 (1.86–8.11) <0.001 4.16 (1.96–8.84) <0.001
D 51.4 (19.9–133) <0.001 -
Ischemia test result Negative reference reference
Non-conclusive 1.84 (0.96–3.54) <0.001 2.12 (1.07–4.19) 0.03
Positive 4.38 (2.30–8.35) <0.001 5.21 (2.65–10.3) <0.001
Age 1.00 (0.98–1.04) 0.64 1.00 (0.97–1.03) 0.94
Male 1.30 (0.74–2.26) 0.36 1.26 (0.70–2.29) 0.44
Hypertension 1.09 (0.62–1.90) 0.77 1.20 (0.67–2.16) 0.55
Diabetes 2.13 (1.02–4.45) <0.05 1.80 (0.82–3.98) 0.14
Hypercholesterolemia 1.02 (0.59–1.75) 0.96 1.11 (0.62–1.96) 0.73
Smoking 1.44 (0.83–2.50) 0.20 1.50 (0.83–2.68) 0.18
Family history of CVD 1.03 (0.61–1.74) 0.91 0.98 (0.56–1.70) 0.94
CAC = coronary artery calcification, CVD = cardiovascular disease. Group A: CAC score < 10; group B: CAC score 10–99; group C: CAC score 
100–399; group D: CAC score ≥ 400.BMC Cardiovascular Disorders 2008, 8:38 http://www.biomedcentral.com/1471-2261/8/38
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tion.[22] Moreover, 1 patient had significant CAD,
despite a CAC score of 0. This underlines the fact that clin-
ical presentation and cardiovascular risk factors have
always to be taken into account. This finding is confirmed
by another previous study, where CAD was diagnosed in
9 patients (age 50 ± 9, 77% female) with a CAC score of
0. [23] Conversely, our patient was 71-year old women
with a CAC score of 0. This illustrates that CAD can be
diagnosed independent of low scores of coronary calcifi-
cation, although it is very unlikely.
The potential influence of CAC score on decision making
in stable patients without ischemia remains to be eluci-
dated. The negative predictive value of SPECT has been
well established. [24] On the other hand, the prognostic
value of increased CAC scores has also been extensively
shown. [11] The question 'What to do in case of a high
CAC score and a negative SPECT' can not easily been
answered. In several studies the diagnostic values of
SPECT and CAC score have been compared. [20,25,26]
Specificity and sensitivity of CAC score seems higher or at
least equivalent in most studies. In addition, the latter
study suggests that CAC score may be useful preceding
SPECT, in order to filter out the patients with a low prob-
ability at a positive SPECT. However, it is not known
whether patients with a high CAC score benefit from
revascularization; it is known that patients with positive
ischemia test results benefit from revascularization. [24]
So, the specific role and place of the CAC score in the diag-
nostic process has to be determined.
Study limitations
The retrospective design of this study may have intro-
duced bias in patient referral for CAG. Indeed, the deci-
sion to perform CAG was not only based on CAC score,
but also clinical judgement, cardiovascular risk, and
symptomatic status. Due to the nature of this study this
can not be prevented. Only 70 patients with a CAC score
of ≥ 400 were present. The clinical advice to perform a
CAG in case of a CAC ≥ 400 has introduced a bias. How-
ever, despite this clinical advice, only 60 of these 70
patients were referred for CAG. In comparison, 14
patients of 221 with CAC score of 0 were referred for CAG.
Furthermore, not all patients underwent ischemia tests.
However, these data give a good representation of the
impact of EBCT on daily clinical decision making.
Conclusion
Our data suggest that CAC scores can be used in daily clin-
ical practice, in combination with other available diagnos-
tic information, as an aid in further decision making.
Future studies to develop the CAC score as a means to
triage patients towards more expensive and complex diag-
nostic tools are needed and will determine the ultimate
role of the CAC score in cardiovascular medicine.
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